Long‐Term Safety and Efficacy of JR‐131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study-Reference-Cited by-同舟云学术

Long‐Term Safety and Efficacy of JR‐131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study

Published:2019-08-19 Issue:2 Volume:24 Page:136-145
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Nishi Shinichi¹,Yamada Masayuki²,Tsuruya Kazuhiko³,Masakane Ikuto⁴,Nakamoto Hidetomo⁵

Affiliation:

1. Division of Nephrology and Kidney CenterKobe University Graduate School of Medicine Kobe Japan

2. Data Science DivisionKissei Pharmaceutical Co. Tokyo Japan

3. Department of NephrologyNara Medical University Nara Japan

4. Honcho Yabuki Clinic Yamagata Japan

5. Department of General Internal MedicineSaitama Medical University Saitama Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13420

Reference21 articles.

1. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels;Brattich M;Nephrol Nurs J,2006

2. An expert opinion on the current treatment of anemia in patients with kidney disease

3. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease

4. Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS

5. Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicochemical and biological evaluation of JR-131 as a biosimilar to a long-acting erythropoiesis-stimulating agent darbepoetin alfa;PLOS ONE;2020-04-17

2. The first World Health Organization International Standard for in vitro biological activity of darbepoetin;Biologicals;2020-01